IMPACT Therapeutics, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for IMPACT Therapeutics, Inc..The latest application filed is for "substituted fused heteroaromatic tricyclic compounds as kinase inhibitors and the use thereof".

Company Profile

20.20.19

IMPACT Therapeutics, Inc. - Jiangsu N/A CN
IMPACT THERAPEUTICS, INC. - Shanghai CN
IMPACT THERAPEUTICS, INC - Shanghai CN
Impact Therapeutics, Inc. - Nanjing CN
IMPACT Therapeutics, Inc. - Nanjing, Jiangsu N/A CN
IMPACT THERAPEUTICS, INC. - CN CN
IMPACT Therapeutics, Inc. - Ninjing Jiangsu Province CN
IMPACT Therapeutics, Inc. - Nanjing, JS CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
1-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof Grant 11,358,955 - Cai , et al. June 14, 2	2022-06-14
Solid pharmaceutical formulation of PARP inhibitors and use thereof Grant 11,179,392 - Cai , et al. November 23, 2	2021-11-23
Substituted Fused Heteroaromatic Tricyclic Compounds as Kinase Inhibitors and The Use Thereof App 20210128535 - CAI; Suixiong ; et al.	2021-05-06
Substituted fused heteroaromatic compounds as kinase inhibitors and the use thereof Grant 10,874,670 - Cai , et al. December 29, 2	2020-12-29
8,9-DIHYDROIMIDAZO[1,2-a]PYRIMIDO[5,4-e]PYRIMIDIN-5(6H)-ONES App 20200385394 - CAI; Sui Xiong ; et al.	2020-12-10
8,9-dihydroimidazo[1,2-a]pyrimido[5,4-e]pyrimidin-5(6H)-ones Grant 10,703,759 - Cai , et al.	2020-07-07
N-(3-heteroarylaryl)-4-arylarylcarboxamides and analogs as hedgehog pathway inhibitors and use thereof Grant 10,676,468 - Cai , et al.	2020-06-09
IMIDAZO[1,2-b]PYRIMIDO[4,5-d]PYRIDAZIN-5(6H)-ONES AND THE USE THEREOF App 20200131192 - CAI; Suixiong ; et al.	2020-04-30
Process for the preparation of 1-(arylmethyl)quinazoline-2,4(1H,3H)-diones Grant 10,562,889 - Cai , et al. Feb	2020-02-18
Substituted Fused Heteroaromatic Compounds as Kinase Inhibitors and the Use Thereof App 20190358225 - CAI; Suixiong ; et al.	2019-11-28
8,9-DIHYDROIMIDAZO[1,2-a]PYRIMIDO[5,4-e]PYRIMIDIN-5(6H)-ONES App 20190308984 - CAI; Sui Xiong ; et al.	2019-10-10
1-(Arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP Inhibitors and the Use Thereof App 20190270732 - CAI; Sui Xiong ; et al.	2019-09-05
Application Of Hedgehog Pathway Inhibitor In Treating Fibrosis Diseases App 20190255042 - CAI; Sui Xiong ; et al.	2019-08-22
1-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof Grant 10,316,027 - Cai , et al.	2019-06-11
Process For The Preparation Of 1-(arylmethyl)quinazoline-2,4(1h,3h)-diones App 20190112298 - CAI; Suixiong ; et al.	2019-04-18
1-(Arylmethyl)quinazoline-2,4(1H,3H)-Diones as PARP Inhibitors and the Use Thereof App 20180215741 - CAI; Sui Xiong ; et al.	2018-08-02
1-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof Grant 9,926,304 - Cai , et al. March 27, 2	2018-03-27
Solid Pharmaceutical Formulation of PARP Inhibitors and Use Thereof App 20180071290 - CAI; Suixiong ; et al.	2018-03-15
1-(Arylmethyl)quinazoline-2,4(1H,3H)-Diones as PARP Inhibitors and the Use Thereof App 20160237070 - CAI; Sui Xiong ; et al.	2016-08-18
1-(Arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof Grant 9,290,460 - Cai , et al. March 22, 2	2016-03-22
1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof Grant 9,102,631 - Cai , et al. August 11, 2	2015-08-11
Quinazolinediones and their use Grant 9,090,568 - Liu , et al. July 28, 2	2015-07-28
N-(3-heteroarylaryl)-4-arylarylcarboxamides and Analogs as Hedgehog Pathway Inhibitors and Use Thereof App 20150191460 - Cai; Suixiong ; et al.	2015-07-09
1-(Arylmethyl)-5,6,7,8-tetrahydroquinazolline-2,4-diones and Analogs and the Use Thereof App 20140275711 - Cai; Suixiong ; et al.	2014-09-18
1-(Arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP Inhibitors and the Use Thereof App 20140023642 - Cai; Sui Xiong ; et al.	2014-01-23
3-Aryl-6-aryl-[1,2,4]triazolo[4,3-alpha]pyridines as Inhibitors of Cell Proliferation and the Use Thereof App 20130280245 - Cai; Suixiong ; et al.	2013-10-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.